Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Pembrolizumab

Colitis: case report

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Spalart V, et al. Dramatic response to first line single agent pembrolizumab in anaplastic thyroid carcinoma. Case Reports in Endocrinology 2019: 26 Nov 2019. Available from: URL: http://doi.org/10.1155/2019/9095753

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Pembrolizumab. Reactions Weekly 1790, 190 (2020). https://doi.org/10.1007/s40278-020-74808-x

    Download citation